Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1.Paid sources
1.4.1.2.Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Europe blood and blood components industry 3600 synopsis, 2013-2024 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. End-use trends
2.1.5. Country trends
Chapter 3. Europe Blood and Blood Components Industry Insights
3.1. Industry segmentation
3.2.Industry landscape, 2013 - 2024 (USD Million)
3.3.Industry impact factors
3.3.1.Growth drivers
3.3.1.1.Growing prevalence of chronic and infectious diseases
3.3.1.2.Increasing number of trauma cases
3.3.1.3.Expanding geriatric population coupled with growing applications of blood derivatives
3.3.1.4.Rising awareness regarding blood donations in few European countries
3.3.2.Industry pitfalls & challenges
3.3.2.1. Risk of transmission of infections through transfused blood
3.3.2.2.Growing initiatives for better use of blood
3.4. Growth potential analysis
3.4.1.By product
3.4.2.By application
3.4.3.By end-use
3.5. Regulatory landscape
3.6.Porter’s analysis
3.7.Competitive landscape, 2017
3.7.1.Strategy dashboard
3.8. PESTEL analysis
Chapter 4. Europe Blood and Blood Components Market, By Product
4.1. Key segment trends
4.2. Whole blood
4.2.1.1.Market size, by country, 2013 – 2024 (USD Million)
4.3. Blood components
4.3.1.1.Market size, by country, 2013 – 2024 (USD Million)
4.3.1.2.Market size, by country, 2013 – 2024 (Units)
4.3.2. Red blood cells
4.3.2.1. Market size, by country, 2013 – 2024 (USD Million)
4.3.2.2.Market size, by country, 2013 – 2024 (Units)
4.3.3. Platelets
4.3.3.1. Market size, by country, 2013 – 2024 (USD Million)
4.3.3.2.Market size, by country, 2013 – 2024 (Units)
4.3.4. Plasma
4.3.4.1. Market size, by country, 2013 – 2024 (USD Million)
4.3.4.2.Market size, by country, 2013 – 2024 (Units)
4.3.5. White blood cells
4.3.5.1. Market size, by country, 2013 – 2024 (USD Million)
4.3.5.2.Market size, by country, 2013 – 2024 (Units)
Chapter 5. Europe Blood and Blood Components Market, By Application
5.1. Key segment trends
5.2. Anemia
5.2.1.Market size, by country, 2013 – 2024 (USD Million)
5.3. Trauma & surgery
5.3.1.Market size, by country, 2013 – 2024 (USD Million)
5.4. Cancer treatment
5.4.1.Market size, by country, 2013 – 2024 (USD Million)
5.5. Bleeding disorders
5.5.1.Market size, by country, 2013 – 2024 (USD Million)
5.6. Others
5.6.1.Market size, by country, 2013 – 2024 (USD Million)
Chapter 6. Europe Blood and Blood Components Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1.Market size, by country, 2013 – 2024 (USD Million)
6.3. Ambulatory surgical centers
6.3.1.Market size, by country, 2013 – 2024 (USD Million)
6.4. Others
6.4.1.Market size, by country, 2013 – 2024 (USD Million)
Chapter 7.Europe Blood and Blood Components Market, By Country
7.1. Key country trends
7.2. Europe
7.2.1.Market size, by country, 2013-2024 (USD)
7.2.2.Market size, by product, 2013-2024 (USD)
7.2.2.1.Market size, by blood components, 2013-2024 (USD)
7.2.2.2.Market size, by blood components, 2013-2024 (Units)
7.2.3.Market size, by application, 2013-2024 (USD)
7.2.4.Market size, by end-use, 2013-2024 (USD)
7.2.5. Germany
7.2.5.1.1. Market size, by product, 2013-2024 (USD)
7.2.5.1.1.1. Market size, by blood components, 2013-2024 (USD)
7.2.5.1.1.2.Market size, by blood components, 2013-2024 (Units)
7.2.5.1.2. Market size, by application, 2013-2024 (USD)
7.2.5.1.3.Market size, by end-use, 2013-2024 (USD)
7.2.6. UK
7.2.6.1.1. Market size, by product, 2013-2024 (USD)
7.2.6.1.1.1. Market size, by blood components, 2013-2024 (USD)
7.2.6.1.1.2.Market size, by blood components, 2013-2024 (Units)
7.2.6.1.2. Market size, by application, 2013-2024 (USD)
7.2.6.1.3.Market size, by end-use, 2013-2024 (USD)
7.2.7. France
7.2.7.1.1. Market size, by product, 2013-2024 (USD)
7.2.7.1.1.1. Market size, by blood components, 2013-2024 (USD)
7.2.7.1.1.2.Market size, by blood components, 2013-2024 (Units)
7.2.7.1.2. Market size, by application, 2013-2024 (USD)
7.2.7.1.3. Market size, by end-use, 2013-2024 (USD)
7.2.8. Spain
7.2.8.1.1. Market size, by product, 2013-2024 (USD)
7.2.8.1.1.1. Market size, by blood components, 2013-2024 (USD)
7.2.8.1.1.2.Market size, by blood components, 2013-2024 (Units)
7.2.8.1.2. Market size, by application, 2013-2024 (USD)
7.2.8.1.3. Market size, by end-use, 2013-2024 (USD)
7.2.9. Italy
7.2.9.1.1. Market size, by product, 2013-2024 (USD)
7.2.9.1.1.1. Market size, by blood components, 2013-2024 (USD)
7.2.9.1.1.2.Market size, by blood components, 2013-2024 (Units)
7.2.9.1.2. Market size, by application, 2013-2024 (USD)
7.2.9.1.3.Market size, by end-use, 2013-2024 (USD)
7.2.10. Russia
7.2.10.1.1. Market size, by product, 2013-2024 (USD)
7.2.10.1.1.1. Market size, by blood components, 2013-2024 (USD)
7.2.10.1.1.2.Market size, by blood components, 2013-2024 (Units)
7.2.10.1.2. Market size, by application, 2013-2024 (USD)
7.2.10.1.3.Market size, by end-use, 2013-2024 (USD)
Chapter 8.Company Profiles
8.1. American Association of Blood Banks (AABB)
8.1.1. Business overview
8.1.2.Financial data
8.1.3.Product landscape
8.1.4.Strategic outlook
8.1.5.SWOT analysis
8.2. AVIS National
8.2.1. Business overview
8.2.2.Financial data
8.2.3.Product landscape
8.2.4.Strategic outlook
8.2.5.SWOT analysis
8.3. International Federation of Red Cross and Red Crescent Societies (IFRC)
8.3.1. Business overview
8.3.2.Financial data
8.3.3.Product landscape
8.3.4.Strategic outlook
8.3.5.SWOT analysis
8.4. NHS Blood and Transplant (NHSBT)
8.4.1. Business overview
8.4.2.Financial data
8.4.3.Product landscape
8.4.4.Strategic outlook
8.4.5.SWOT analysis
8.5. Northern Ireland Blood Transfusion Service
8.5.1. Business overview
8.5.2.Financial data
8.5.3.Product landscape
8.5.4.Strategic outlook
8.5.5.SWOT analysis
8.6. Scottish National Blood Transfusion Service(NHS National Services Scotland)
8.6.1. Business overview
8.6.2.Financial data
8.6.3.Product landscape
8.6.4.Strategic outlook
8.6.5.SWOT analysis
8.7. Welsh Blood Service
8.7.1. Business overview
8.7.2.Financial data
8.7.3.Product landscape
8.7.4.Strategic outlook
8.7.5.SWOT analysis
